Inventor · disambiguated record
Kandasamy Ramasamy
Also filed as: RAMASAMY KANDASAMY
11 granted patents·2 pending applications·807 citations·filing 1994–2003
93Inventor score
Top patents by PatentIndex Score
13 records- 0198US6573248B2Monocyclic L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2001·Granted Jun 3, 2003·179 cites·10 claims
- 0296US6130326AMonocyclic L-Nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 1999·Granted Oct 10, 2000·139 cites·4 claims
- 0395US6552183B1Moncyclic L-nucleosides analogsICN PHARMACEUTICALS·Filed 2000·Granted Apr 22, 2003·74 cites·2 claims
- 0494US6262241B1Compound for detecting and modulating RNA activity and gene expressionISIS PHARMACEUTICALS INC·Filed 1995·Granted Jul 17, 2001·190 cites·29 claims
- 0594US5681940ASugar modified nucleosides and oligonucleotidesICN PHARMACEUTICALS·Filed 1994·Granted Oct 28, 1997·140 cites·9 claims
- 0679US5969135AOligonucleotide analogs with an amino acid or a modified amino alcohol residueICN PHARMACEUTICALS·Filed 1995·Granted Oct 19, 1999·28 cites·9 claims
- 0775US6423695B1Cytokine related treatments of diseaseRIBAPHARM INC·Filed 1999·Granted Jul 23, 2002·34 cites·12 claims
- 0869US7638496B2Nucleoside analogs with carboxamidine modified monocyclic baseVALEANT PHARMACEUTICALS NORTH·Filed 2002·Granted Dec 29, 2009·1 cites·4 claims
- 0961US2003207826A1Cytokine related treatments of diseaseFiled 2003·Application pending·0 cites
- 1058US2002132784A1Cytokine related treatments of diseaseFiled 2002·Application pending·0 cites
- 1154US5907036AProcedures for obtaining ribo-C-nucleosidesICN PHARMACEUTICALS·Filed 1996·Granted May 25, 1999·7 cites·11 claims
- 1253US6613896B1Method of producing tiazofurin and other C-nucleosidesICN PHARMACEUTICALS·Filed 1998·Granted Sep 2, 2003·9 cites·21 claims
- 1342US6211201B1Multivalent salts of pyridostigmine and related compoundsICN PHARMACEUTICALS·Filed 1997·Granted Apr 3, 2001·6 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Kandasamy Ramasamy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →